Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMJ Open|March 11, 2019
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)Sergio Leonardi, Anna Franzone, Raffaele Piccolo, et al.
Journal of the American College of Cardiology|November 2, 2019
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary StentingAnna Franzone, Eugène McFadden, Sergio Leonardi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 18, 2019
Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trialMariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, et al.
Circulation. Cardiovascular Quality and Outcomes|February 4, 2021
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSYSergio Leonardi, Mattia Branca, Anna Franzone, et al.
International Journal of Cardiology|March 9, 2019
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS studyPly Chichareon, Rodrigo Modolo, David van Klaveren, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
Lancet (London, England)|March 5, 2019
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trialAzfar Zaman, Robbert J de Winter, Norihiro Kogame, et al.
Cardiology Journal|May 22, 2025
Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?Jacek Kubica, Piotr Adamski, Katarzyna Buszko, et al.
ESC Heart Failure|November 17, 2021
Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study)Jacek Kubica, Małgorzata Ostrowska, Wioleta Stolarek, et al.
Cardiology Journal|January 18, 2023
Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: A subanalysis of the COV-HF-SIRIO 6 studyMałgorzata Ostrowska, Michał Kasprzak, Wioleta Stolarek, et al.
Pageof 3